Literature DB >> 30217435

CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety.

Kristen E Pleil1, Mary Jane Skelly2.   

Abstract

Decades of research have described the importance of corticotropin-releasing factor (CRF) signaling in alcohol addiction, as well as in commonly co-expressed neuropsychiatric diseases, including anxiety and mood disorders. However, CRF signaling can also acutely regulate binge alcohol consumption, anxiety, and affect in non-dependent animals, possibly via modulation of central monoaminergic signaling. We hypothesize that basal CRF tone is particularly high in animals and humans with an inherent propensity for high anxiety and alcohol consumption, and thus these individuals are at increased risk for the development of alcohol use disorder and comorbid neuropsychiatric diseases. The current review focuses on extrahypothalamic CRF circuits, particularly those stemming from the bed nucleus of the stria terminalis (BNST), found to play a role in basal phenotypes, and examines whether the intrinsic hyperactivity of these circuits is sufficient to escalate the expression of these behaviors and steepen the trajectory of development of disease states. We focus our efforts on describing CRF modulation of biogenic amine neuron populations that have widespread projections to the forebrain to modulate behaviors, including alcohol and drug intake, stress reactivity, and anxiety. Further, we review the known sex differences and estradiol modulation of these neuron populations and CRF signaling at their synapses to address the question of whether females are more susceptible to the development of comorbid addiction and stress-related neuropsychiatric diseases because of hyperactive extrahypothalamic CRF circuits compared to males.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol; Anxiety; Bed nucleus of the stria terminalis (BNST); Corticotropin releasing factor (CRF); Dopamine (DA); Estrogen; Norepinephrine (NE); Serotonin (5-HT)

Mesh:

Substances:

Year:  2018        PMID: 30217435      PMCID: PMC6141347          DOI: 10.1016/j.alcohol.2018.01.007

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  301 in total

1.  Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus.

Authors:  Beverly A S Reyes; Krysta Fox; Rita J Valentino; Elisabeth J Van Bockstaele
Journal:  Eur J Neurosci       Date:  2006-06       Impact factor: 3.386

2.  Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats.

Authors:  Andrea Cippitelli; Ruslan Damadzic; Erick Singley; Annika Thorsell; Roberto Ciccocioppo; Robert L Eskay; Markus Heilig
Journal:  Pharmacol Biochem Behav       Date:  2011-10-20       Impact factor: 3.533

3.  Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.

Authors:  Leandro F Vendruscolo; David Estey; Vivian Goodell; Lauren G Macshane; Marian L Logrip; Joel E Schlosburg; M Adrienne McGinn; Eva R Zamora-Martinez; Joseph K Belanoff; Hazel J Hunt; Pietro P Sanna; Olivier George; George F Koob; Scott Edwards; Barbara J Mason
Journal:  J Clin Invest       Date:  2015-06-29       Impact factor: 14.808

4.  Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men.

Authors:  M C Austin; J E Janosky; H A Murphy
Journal:  Mol Psychiatry       Date:  2003-03       Impact factor: 15.992

Review 5.  The role of mesoprefrontal dopamine neurons in stress.

Authors:  B A Horger; R H Roth
Journal:  Crit Rev Neurobiol       Date:  1996

6.  Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice.

Authors:  Simranjit Kaur; Ju Li; Mary P Stenzel-Poore; Andrey E Ryabinin
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

7.  Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis.

Authors:  W E Cullinan; J P Herman; S J Watson
Journal:  J Comp Neurol       Date:  1993-06-01       Impact factor: 3.215

8.  Neuroanatomical characterization of endogenous opioids in the bed nucleus of the stria terminalis.

Authors:  Jean-François Poulin; Danielle Arbour; Sylvie Laforest; Guy Drolet
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-07-04       Impact factor: 5.067

9.  A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice.

Authors:  M Foster Olive; Kristin K Mehmert; Heather N Koenig; Rosana Camarini; Joseph A Kim; Michelle A Nannini; Christine J Ou; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2002-10-24       Impact factor: 4.530

Review 10.  Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders.

Authors:  M A Lebow; A Chen
Journal:  Mol Psychiatry       Date:  2016-02-16       Impact factor: 13.437

View more
  7 in total

Review 1.  A role for the neuropeptide somatostatin in the neurobiology of behaviors associated with substances abuse and affective disorders.

Authors:  Stacey L Robinson; Todd E Thiele
Journal:  Neuropharmacology       Date:  2020-02-03       Impact factor: 5.250

2.  Predictors of COVID-19-related health anxiety among health care workers: a cross-sectional study.

Authors:  Maryam Saeedi; Sahar Yazdi; Rasoul Corani Bahador
Journal:  BMC Psychol       Date:  2022-07-11

3.  Divergent behavioral responses in protracted opioid withdrawal in male and female C57BL/6J mice.

Authors:  Isabel M Bravo; Brennon R Luster; Meghan E Flanigan; Patric J Perez; Elizabeth S Cogan; Karl T Schmidt; Zoe A McElligott
Journal:  Eur J Neurosci       Date:  2019-10-06       Impact factor: 3.386

4.  Sex differences in corticotropin releasing factor peptide regulation of inhibitory control and excitability in central amygdala corticotropin releasing factor receptor 1-neurons.

Authors:  Abigail E Agoglia; Jyoshitha Tella; Melissa A Herman
Journal:  Neuropharmacology       Date:  2020-09-17       Impact factor: 5.250

5.  Alterations in connectivity of the bed nucleus of the stria terminalis during early abstinence in individuals with alcohol use disorder.

Authors:  Elizabeth A Flook; Brandee Feola; Margaret M Benningfield; Marisa M Silveri; Danny G Winder; Jennifer Urbano Blackford
Journal:  Alcohol Clin Exp Res       Date:  2021-04-08       Impact factor: 3.455

6.  Health anxiety in medical employees: A multicentre study.

Authors:  Qingsong Chen; Yuqun Zhang; Dongyun Zhuang; Xueqin Mao; Guolin Mi; Dijuan Wang; Xiangdong Du; Zhenghui Yi; Xinhua Shen; Yuxiu Sui; Huajie Li; Yin Cao; Zufu Zhu; Zhenghua Hou; Qibin Li; Yonggui Yuan
Journal:  J Int Med Res       Date:  2019-09-06       Impact factor: 1.671

7.  Single neonatal dexamethasone administration has long-lasting outcome on depressive-like behaviour, Bdnf, Nt-3, p75ngfr and sorting receptors (SorCS1-3) stress reactive expression.

Authors:  D A Lanshakov; E V Sukhareva; V V Bulygina; A V Bannova; E V Shaburova; T S Kalinina
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.